BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 18211429)

  • 1. 1% topical cidofovir used as last alternative to treat viral infections.
    Briand S; Milpied B; Navas D; Thomare P; Stalder JF
    J Eur Acad Dermatol Venereol; 2008 Feb; 22(2):249-50. PubMed ID: 18211429
    [No Abstract]   [Full Text] [Related]  

  • 2. Topical cidofovir for molluscum contagiosum in children.
    Zabawski EJ; Cockerell CJ
    Pediatr Dermatol; 1999; 16(5):414-5. PubMed ID: 10627225
    [No Abstract]   [Full Text] [Related]  

  • 3. Topical cidofovir: a novel treatment for recalcitrant molluscum contagiosum in children infected with human immunodeficiency virus 1.
    Toro JR; Wood LV; Patel NK; Turner ML
    Arch Dermatol; 2000 Aug; 136(8):983-5. PubMed ID: 10926733
    [No Abstract]   [Full Text] [Related]  

  • 4. Topical cidofovir for severe cutaneous human papillomavirus and molluscum contagiosum infections in patients with HIV/AIDS. A pilot study.
    Calista D
    J Eur Acad Dermatol Venereol; 2000 Nov; 14(6):484-8. PubMed ID: 11444271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical cidofovir and cryotherapy--combination treatment for recalcitrant molluscum contagiosum in a patient with HIV infection.
    Baxter KF; Highet AS
    J Eur Acad Dermatol Venereol; 2004 Mar; 18(2):230-1. PubMed ID: 15009318
    [No Abstract]   [Full Text] [Related]  

  • 6. [Efficacy and safety of intravenous cidofovir in the treatment of giant molluscum contagiosum in an immunosuppressed patient].
    Foissac M; Goehringer F; Ranaivo IM; May T; Cuny JF; Schmutz JL; Lekaditi M
    Ann Dermatol Venereol; 2014 Oct; 141(10):620-2. PubMed ID: 25288067
    [No Abstract]   [Full Text] [Related]  

  • 7. Efflorescence of facial molluscum contagiosum as a manifestation of immune reconstitution inflammatory syndrome in a patient with AIDS.
    Bachmeyer C; Moguelet P; Baud F; Lescure FX
    Eur J Dermatol; 2009; 19(3):257-8. PubMed ID: 19213651
    [No Abstract]   [Full Text] [Related]  

  • 8. New human papillomavirus (HPV) types involved in epidermodysplasia verruciformis (EV) in 3 HIV-infected patients: response to topical cidofovir.
    Darwich E; Darwich L; Cañadas MP; Klaustermeier J; Ercilla G; Alsina-Gibert M; Mascaró JM
    J Am Acad Dermatol; 2011 Aug; 65(2):e43-e45. PubMed ID: 21763546
    [No Abstract]   [Full Text] [Related]  

  • 9. Topical and intralesional cidofovir: a review of pharmacology and therapeutic effects.
    Zabawski EJ; Cockerell CJ
    J Am Acad Dermatol; 1998 Nov; 39(5 Pt 1):741-5. PubMed ID: 9810890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous cidofovir-induced resolution of disfiguring cutaneous human papillomavirus infection.
    Kottke MD; Parker SR
    J Am Acad Dermatol; 2006 Sep; 55(3):533-6. PubMed ID: 16908370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical cidofovir for viral warts in children.
    Fernández-Morano T; del Boz J; González-Carrascosa M; Tortajada B; de Troya M
    J Eur Acad Dermatol Venereol; 2011 Dec; 25(12):1487-9. PubMed ID: 21261749
    [No Abstract]   [Full Text] [Related]  

  • 12. Topical cidofovir for severe molluscum contagiosum.
    Davies EG; Thrasher A; Lacey K; Harper J
    Lancet; 1999 Jun; 353(9169):2042. PubMed ID: 10376628
    [No Abstract]   [Full Text] [Related]  

  • 13. [Intralesional cidofovir in human papilomavirus infection in interdigital spaces].
    Pi Sala N; Figueras Suriol A; Ramió Montero E
    Farm Hosp; 2017 Jan; 41(n01):132-133. PubMed ID: 28045657
    [No Abstract]   [Full Text] [Related]  

  • 14. Wiskott-Aldrich syndrome and molluscum contagiosum: a therapeutic challenge after reaction to cidofovir.
    Hicks LD; Duvic M
    Int J Dermatol; 2008 Dec; 47(12):1304-5. PubMed ID: 19126022
    [No Abstract]   [Full Text] [Related]  

  • 15. The management of oral human papillomavirus with topical cidofovir: a case report.
    DeRossi SS; Laudenbach J
    Cutis; 2004 Mar; 73(3):191-3. PubMed ID: 15074348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful treatment of refractory cutaneous warts using topical 3% cidofovir in a child after heart transplant.
    Cleary A; Watson R; McMahon CJ
    J Heart Lung Transplant; 2014 Sep; 33(9):971-2. PubMed ID: 24726426
    [No Abstract]   [Full Text] [Related]  

  • 17. Intralesional or topical cidofovir (HPMPC, VISTIDE) for the treatment of recurrent genital warts in HIV-1-infected patients.
    Orlando G; Fasolo MM; Beretta R; Signori R; Adriani B; Zanchetta N; Cargnel A
    AIDS; 1999 Oct; 13(14):1978-80. PubMed ID: 10513659
    [No Abstract]   [Full Text] [Related]  

  • 18. Resolution of recalcitrant human papillomavirus gingival infection with topical cidofovir.
    Calista D
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2000 Dec; 90(6):713-5. PubMed ID: 11113816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel treatment of atypical human papillomavirus-associated epithelial hyperplasia with cidofovir.
    Collette DC; Zechel MA
    J Oral Maxillofac Surg; 2011 Sep; 69(9):2383-6. PubMed ID: 21292369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical cidofovir for severe warts in a patient affected by AIDS and Hodgkin's lymphoma.
    De Socio GV; Simonetti S; Rosignoli D; Minga P; Tomassini GM; Baldelli F
    Int J STD AIDS; 2008 Oct; 19(10):715-6. PubMed ID: 18824628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.